why choose us

First received: November 01, 2023

Clinical Trial: A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Advanced Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Brief Summary: The primary purpose of this study is to assess the safety and tolerability of AB801 in participants with advanced malignancies, and to determine a recommended AB801 dose for expansion.

Read more